Context.—The upgrade rate to carcinoma on excision for atypical lobular hyperplasia
diagnosed on breast biopsy is controversial. Objective.—To review cases with isolated …

Design We evaluated all cases of ALH on core biopsy from 1999 to 2009 from our institution,
focusing on cases with≤ 3 foci of ALH (minimal), paired excision, and no other lesion on the …

Purpose To assess the utility of precise radiologic and pathologic correlation for establishing
imaging-histologic concordance or discordance as a method to limit the number of patients …

The appropriate follow-up and treatment for patients with a core biopsy diagnosis of lobular
neoplasia (atypical lobular hyperplasia or lobular carcinoma in situ) remains controversial …

A core biopsy diagnosis of atypical ductal epithelial hyperplasia is upstaged on follow-up
excisional biopsy (FUEB) to in situ or invasive carcinoma in about 20% of cases, thus …

Lobular neoplasia (LN), including atypical lobular hyperplasia (ALH) and lobular carcinoma
in situ, may be encountered in breast core biopsies performed for mammographic …

OBJECTIVE. The purpose of this article is to determine the upgrade rate to ductal carcinoma
in situ (DCIS) or invasive carcinoma at excision at the same site after percutaneous breast …

PURPOSE: To review outcomes of lesions diagnosed at core-needle breast biopsy as
atypical lobular hyperplasia (ALH) or lobular carcinoma in situ (LCIS). MATERIALS AND …

Lobular neoplasia including lobular carcinoma in situ (LCIS) and atypical lobular
hyperplasia (ALH) may be identified in breast core needle biopsies as incidental findings or …

OBJECTIVE. The aims of our study were to determine the frequency of malignancy after
surgical excision of biopsy-proven lobular carcinoma in situ (LCIS) or atypical lobular …